Picture of Gamida Cell logo

GMDAQ — Gamida Cell News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Gamida Cell Ltd expected to post a loss of 31 cents a share - Earnings Preview

* Gamida Cell Ltd  GMDA.OQ   GMDA.O  is expected to show no
change
in quarterly revenue when it reports  results on November 14. 
    * 
    * ​Refinitiv's mean analyst estimate for Gamida Cell Ltd is
for a
loss of 31 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Gamida Cell
Ltd
is $15​, above​ its last closing price of $1.86. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.29       -0.29      -0.31     Missed  -6.2
 Mar. 31 2022  -0.34       -0.34      -0.34     Met     0
 Dec. 31 2021  -0.40       -0.40      -0.52     Missed  -28.4​
 Sep. 30 2021  -0.49       -0.48      -0.33     Beat    31.3
 ​​Jun.        -0.39       -0.40      -0.36     Beat    10.4
 30 2021                                                
 Mar. 31 2021  -0.40       -0.40      -0.31     Beat    22.2​
 Dec. 31 2020  -0.34       -0.34      -0.68     Missed  -98.1
 Sep. 30 2020  -0.31       -0.31      -0.30     Beat    4.3
 This summary was machine generated November 11 at 17:22 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Gamida Cell

See all news